Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
Fennec Pharmaceuticals Inc. (FENC)
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.fennecpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
Net Product Sales (Full Year 2025): $44.6 million, up 50% from $29.6 million in 2024. Selling and Marketing Expenses (Q4 2025): $6.1 million, compared to $3.9 million in Q4 2024. Selling and Marketing Expenses (Full Year 2025): $18.6 million, compared to $18.4 million in 2024. General and Administrative Expenses (Q4 2025): $8.9 million, compared to $4.2 million in Q4 2024. General and Administrative Expenses (Full Year 2025): $28.8 million, compared to $23.1 million in 2024. Cash and Cash Equivalents (End of 2025): $36.8 million. Debt: Fully redeemed, with zero debt outstanding as of the end of 2025. Net Proceeds from Equity Offerings: Approximately $42 million. Patent Litigation Settlement: Cipla's generic entry delayed until September 1, 2033, providing market exclusivity. Warning! GuruFocus has detected 6 Warning Signs with FENC. Is FENC fairly valued? Test your thesis with our free DCF calculator. Release Date: March 24, 2026 For the complete transcript of
Show less
Read more
Impact Snapshot
Event Time:
FENC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FENC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FENC alerts
High impacting Fennec Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
FENC
News
- Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M [Seeking Alpha]Seeking Alpha
- Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 [Yahoo! Finance]Yahoo! Finance
- Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026GlobeNewswire
- Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation [Yahoo! Finance]Yahoo! Finance
FENC
Earnings
- 3/24/26 - Miss
FENC
Sec Filings
- 3/24/26 - Form 8-K
- 3/16/26 - Form 8-K
- 3/11/26 - Form 4
- FENC's page on the SEC website